1. Add the template
Paste this content into My Templates, or start from a specialty-generated template and edit the sections.
Built for rheumatology follow-ups where interval flares, treatment tolerability, disease-activity measures, and monitoring labs matter more than repeating the entire consult history.
Copy or download, then paste into Wavo under My Templates.
Rheumatology Follow-Up Note Interval History - Joint symptoms, morning stiffness, flares, functional status, and extra-articular symptoms since last visit. - Infections, surgeries, hospitalizations, pregnancy status/plans, and vaccine updates as relevant. - Adherence and tolerability of current rheumatologic therapy; steroid exposure. Disease Activity Measures - Patient/physician global, pain scores, HAQ/RAPID3/DAS28/CDAI/BASDAI or other measures if performed—do not invent scores. Exam - Focused musculoskeletal and relevant systemic exam; swollen/tender joint counts if performed. Data Reviewed - Inflammatory markers, DMARD/biologic safety labs, imaging, and outside records discussed today. Assessment - Disease activity (remission / low / moderate / high) and trajectory. - Treatment toxicity or infection concerns. - Comorbidity issues affecting therapy (e.g., CKD, liver disease, ILD). Plan - Continue, adjust, or switch therapy with rationale; steroid taper plan if applicable. - Labs, imaging, referrals, joint injections, and infection/vaccine counseling. - Follow-up interval and flare precautions.
What makes the structure useful, and which visits it fits best.
Why this template works
Structural advantages for real documentation
Best for
Visit types and clinicians who use this format
Illustrative excerpt of how a visit can land in this structure. Not a real patient record—review and edit every note before signing.
Interval History RA follow-up at 3 months on methotrexate 20 mg weekly + folic acid. Morning stiffness 20 minutes (was 60). Mild MCP aching after typing; no fever or infection. No steroid use this interval. Considering COVID booster. Exam / Measures Synovitis mild at right 2nd MCP only. Patient global 2/10. CDAI low activity today. Lungs clear. Data CBC/CMP/LFTs acceptable for MTX. CRP 0.4 (was 2.1). Hand X-rays deferred given improvement. Assessment Seropositive RA, low disease activity on MTX; well tolerated. Plan Continue MTX 20 mg weekly. Labs in 3 months. Discussed infection precautions and vaccine timing. Return in 3 months or sooner for flare with >3 swollen joints, fever, or unexplained dyspnea.
What the product actually does with your template.
Paste this content into My Templates, or start from a specialty-generated template and edit the sections.
Capture the encounter with ambient recording or dictation. Wavo structures the note using your template.
Edit with Smart Transform if needed, then export or copy into your EHR. You stay responsible for the final note.
Start free, paste the template, and see how Wavo documents in your structure.